Speaker Profile

Ph.D., CEO, Avail Bio

Nima co-founded Avail Bio, a precision medicine company working on increasing the safety and efficacy of cancer immunotherapeutics. Avail's mission is to innovate a new standard for precision medicine using a novel genomic platform, in collaboration with leading cancer centers and with support from Illumina Accelerator and institutional venture capital. Nima received a PhD in Bioinformatics from the UCSF Cancer Center, and studied Bioengineering, Electrical Engineering and Computer Science at UC Berkeley.